Methylation status of TUSC3 is a prognostic factor in ovarian cancer

Current prognostic information in ovarian cancer is based on tumor stage, tumor grade, and postoperative tumor size. Reliable molecular prognostic markers are scarce. In this article, the authors describe epigenetic events in a frequently deleted region on chromosome 8p22 that influence the expression of tumor suppressor candidate 3 (TUSC3), a putative tumor suppressor gene in ovarian cancer.

[1]  D. Matei,et al.  Epigenetic resensitization to platinum in ovarian cancer. , 2012, Cancer research.

[2]  N. Hacker,et al.  Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. , 2012, Cancer letters.

[3]  AA Ahmed,et al.  The origin of ovarian cancer , 2012, BJOG : an international journal of obstetrics and gynaecology.

[4]  P. Laird,et al.  Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer , 2011, PloS one.

[5]  P. Rudd,et al.  5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer , 2011, Epigenetics.

[6]  Kenneth P. Nephew,et al.  Rethinking ovarian cancer: recommendations for improving outcomes , 2011, Nature Reviews Cancer.

[7]  Tak W. Mak,et al.  The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway , 2010, Cell.

[8]  M. Birrer.  The origin of ovarian cancer—is it getting clearer? , 2010, The New England journal of medicine.

[9]  A. Lityńska,et al.  Cell migration-the role of integrin glycosylation. , 2010, Biochimica et biophysica acta.

[10]  Y. Assaraf,et al.  Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. , 2010, Biochemical pharmacology.

[11]  D. Clapham,et al.  Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development , 2009, Proceedings of the National Academy of Sciences.

[12]  R. Glockshuber,et al.  Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency , 2009, Proceedings of the National Academy of Sciences.

[13]  H. Ropers,et al.  A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. , 2008, American journal of human genetics.

[14]  J. Gécz,et al.  Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. , 2008, American journal of human genetics.

[15]  J. Dennis,et al.  Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.

[16]  D. Kelleher,et al.  An evolving view of the eukaryotic oligosaccharyltransferase. , 2006, Glycobiology.

[17]  Peter Horak,et al.  Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma , 2005, Cancer.

[18]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[19]  A. Kobata,et al.  Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours , 2005, Immunology and cell biology.

[20]  Robert Tibshirani,et al.  Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. , 2005, Neoplasia.

[21]  R. Zeillinger,et al.  Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer , 2005, Molecular Cancer Research.

[22]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[23]  Jian Yu,et al.  Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. , 2004, World Journal of Gastroenterology.

[24]  D. Karaoglu,et al.  Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. , 2003, Molecular cell.

[25]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Yamaguchi,et al.  Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[28]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[29]  M. Burg.  Advanced ovarian cancer , 2001, Current treatment options in oncology.

[30]  J. Berek,et al.  Ovarian cancer: epidemiology, biology, and prognostic factors. , 2000, Seminars in surgical oncology.

[31]  Z. Arbieva,et al.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. , 2000, Genome research.

[32]  J. Dennis,et al.  Glycoprotein glycosylation and cancer progression. , 1999, Biochimica et biophysica acta.

[33]  R. Bookstein,et al.  High‐density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p , 1999, Genes, chromosomes & cancer.

[34]  W. Isaacs,et al.  Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. , 1996, Genomics.

[35]  W. Isaacs,et al.  Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. , 1996, Genomics.

[36]  J. Guastalla,et al.  [Advanced ovarian cancer]. , 1995, Soins; la revue de reference infirmiere.

[37]  D. Karaoglu,et al.  Functional characterization of Ost3p. Loss of the 34-kD subunit of the Saccharomyces cerevisiae oligosaccharyltransferase results in biased underglycosylation of acceptor substrates , 1995, The Journal of cell biology.

[38]  P. Walsh,et al.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.

[39]  G. Yogeeswaran,et al.  Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. , 1981, Science.

[40]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[41]  John G. Collard,et al.  Potential of T-Cell Hybridomas Cell Surface Sialic Acid and the Invasive and Metastatic Updated Version , 2006 .

[42]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[43]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[44]  Henry H. Paik,et al.  Imaging, Diagnosis, Prognosis Prognostic DNA Methylation Biomarkers in Ovarian Cancer , 2022 .